Advanced

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials.

Vesikari, Timo; Richardus, Jan Hendrik; Berglund, Johan; Korhonen, Tiina; Flodmark, Carl-Erik LU ; Lindstrand, Ann; Silfverdal, Sven Arne; Bambure, Vinod; Caplanusi, Adrian and Dieussaert, Ilse, et al. (2015) In Pediatric Infectious Disease Journal 34(7). p.774-782
Abstract
During the influenza pandemic 2009-2010, an AS03- adjuvanted A(H1N1)pdm09 vaccine was used extensively in children 6 months of age and older, and during the 2010-2011 influenza season, the A(H1N1)pdm09 strain was included in the seasonal trivalent inactivated influenza vaccine (TIV) without adjuvant. We evaluated the immunogenicity and safety of TIV in children previously vaccinated with the AS03-adjuvanted A(H1N1)pdm09 vaccine.
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Pediatric Infectious Disease Journal
volume
34
issue
7
pages
774 - 782
publisher
Lippincott Williams & Wilkins
external identifiers
  • PMID:26069949
  • Scopus:84942294594
  • WOS:000369586900020
ISSN
1532-0987
DOI
10.1097/INF.0000000000000709
language
English
LU publication?
yes
id
8dc958eb-8df9-435b-99f4-3939719164df (old id 7476958)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26069949?dopt=Abstract
date added to LUP
2015-07-12 18:21:01
date last changed
2016-10-28 15:15:57
@misc{8dc958eb-8df9-435b-99f4-3939719164df,
  abstract     = {During the influenza pandemic 2009-2010, an AS03- adjuvanted A(H1N1)pdm09 vaccine was used extensively in children 6 months of age and older, and during the 2010-2011 influenza season, the A(H1N1)pdm09 strain was included in the seasonal trivalent inactivated influenza vaccine (TIV) without adjuvant. We evaluated the immunogenicity and safety of TIV in children previously vaccinated with the AS03-adjuvanted A(H1N1)pdm09 vaccine.},
  author       = {Vesikari, Timo and Richardus, Jan Hendrik and Berglund, Johan and Korhonen, Tiina and Flodmark, Carl-Erik and Lindstrand, Ann and Silfverdal, Sven Arne and Bambure, Vinod and Caplanusi, Adrian and Dieussaert, Ilse and Roy-Ghanta, Sumita and Vaughn, David W},
  issn         = {1532-0987},
  language     = {eng},
  number       = {7},
  pages        = {774--782},
  publisher    = {ARRAY(0x99e60c8)},
  series       = {Pediatric Infectious Disease Journal},
  title        = {Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials.},
  url          = {http://dx.doi.org/10.1097/INF.0000000000000709},
  volume       = {34},
  year         = {2015},
}